Skip to main content

Health and Medicine

Study to test combination therapy for breast cancer

Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

Read more


New faculty: Tuya Pal, associate professor of medicine and Ingram Associate Professor of Cancer Research

Oct. 26, 2017—A high school science class discussion about how genetic traits are passed down from one generation to another inspired Tuya Pal to pursue a career in clinical genetics. Pal is a physician who specializes in cancer health disparities among diverse populations.

Read more


New faculty: Renã A. S. Robinson, associate professor of chemistry

Oct. 23, 2017—Renã A. S. Robinson’s interest in aging dates back to her childhood. Her mother spent her spare time as a caregiver attending to elderly people with dementia. Now an analytic chemist, Robinson is investigating the science behind this very human condition. She is employing the emerging field of proteomics to study the process of aging as well as neurodegenerative diseases like Alzheimer’s.

Read more


New faculty: Erin Calipari, assistant professor of pharmacology

Oct. 23, 2017—Erin Calipari could be described as a code breaker. Using technologies that allow her to probe the activity of single neurons in awake and behaving animals, she is piecing together the neural code that controls motivation and decision-making.

Read more


Forum highlights strong clinical, translational research efforts

Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.

Read more


Calcium intake and colorectal cancer

Oct. 18, 2017—Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.

Read more


Gender, pain and dementia

Oct. 16, 2017—Understanding sex differences in pain perception could lead to more targeted and effective pain assessment and management strategies in older adults with Alzheimer’s disease.

Read more


New faculty: Mariann Piano, professor of nursing and senior associate dean for research

Oct. 16, 2017—Four to five drinks in an evening. Starting the weekend on Thursday with happy hour. No big deal, right? Wrong, according to Mariann Piano, whose work indicates that binge drinking by young adults 18-30 may lead to vascular dysfunction and increased vulnerability to cardiovascular disease.

Read more


New tools to combat kidney fibrosis

Oct. 13, 2017—Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

Read more


A switch for autoimmunity

Oct. 12, 2017—Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies.

Read more


Researcher targets peanut allergies with Cohen Fund support

Oct. 12, 2017—Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment.

Read more


VIGH receives federal grants to fight kidney disease

Oct. 12, 2017—Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

Read more


Page 7 of 131« First...4567891011...Last »